Rigel Pharmaceuticals, Inc. (RIGL)
46.18
-0.30
(-0.66%)
USD |
NASDAQ |
Aug 31, 16:00
46.18
0.00 (0.00%)
After-Hours: 17:20
Rigel Pharmaceuticals Cash from Operations (Annual) : 75.66M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 75.66M |
| December 31, 2024 | 31.47M |
| December 31, 2023 | -5.743M |
| December 31, 2022 | -73.76M |
| December 31, 2021 | 5.878M |
| December 31, 2020 | -52.18M |
| December 31, 2019 | -41.51M |
| December 31, 2018 | -58.83M |
| December 31, 2017 | -77.56M |
| December 31, 2016 | -75.89M |
| December 31, 2015 | -23.41M |
| December 31, 2014 | -69.75M |
| December 31, 2013 | -86.06M |
| December 31, 2012 | -85.19M |
| Date | Value |
|---|---|
| December 31, 2011 | -69.38M |
| December 31, 2010 | 46.74M |
| December 31, 2009 | -102.78M |
| December 31, 2008 | -103.52M |
| December 31, 2007 | -52.21M |
| December 31, 2006 | -35.84M |
| December 31, 2005 | -35.17M |
| December 31, 2004 | -38.15M |
| December 31, 2003 | -32.44M |
| December 31, 2002 | -34.53M |
| December 31, 2001 | -15.98M |
| December 31, 2000 | -11.59M |
| December 31, 1999 | -7.831M |
| December 31, 1998 | -5.071M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 127.04M |
| Cytokinetics, Inc. | -510.01M |
| Perspective Therapeutics, Inc. | -82.48M |
| Capricor Therapeutics, Inc. | -69.81M |
| ACADIA Pharmaceuticals, Inc. | 109.84M |